Dr. Charles Bennett M.D.

Radiation Oncologist , ROBERT BOISSONEAULT ONCOLOGY INSTITUTE

GLG News by Dr. Charles Bennett M.D., Radiation Oncologist

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Advantages of SenoRx Contura over Mammosite Breast Brachytherapy system.

April 4, 2008

Analysis of:A new player in the growing Breast Brachytherapy field | www.senorx.com

SenoRx has released the Contura system which provides a superior system when compared to the Mammosite Breast Brachytherapy System. These advantages include: 1. Better dosimetry, opening the door for more patients to be treated by avoiding the elimination of some patients due to skin spacing and chest wall considerations. 2. Better reimbursement due to the use of multiple dwell positions used versus just one with the Mammosite system. 3 Ability to drain fluid collection via drainage ports of the Contura system that are not available with the Mammosite system. The SenoRx system is poised to take a large percentage of the market share away from Mammosite.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS